Top Banner

of 119

Brain Tumor Amogh

Apr 06, 2018

Download

Documents

Ravindra Reddy
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/3/2019 Brain Tumor Amogh

    1/119

    APPROACH TO BRAIN

    TUMORS

    DR AMOGH R

    FINAL YR DMRD

  • 8/3/2019 Brain Tumor Amogh

    2/119

  • 8/3/2019 Brain Tumor Amogh

    3/119

    RADIOLOGICAL

    INVESTIGATIONS IN

    INTRACRANIAL TUMOURS

  • 8/3/2019 Brain Tumor Amogh

    4/119

    PLAIN RADIOGRAPHY

    Plain radiographic findings in brain tumours are

    of historical interest, but radiologists should still

    be familiar with signs of raised intracranial

    pressure (ICP) such as erosion of the laminadura of the dorsum sellae, or a J-shaped sella.

    Skull radiography may also demonstrate tumour

    calcification and enlargement of middle

    meningeal artery grooves in meningiomas.

  • 8/3/2019 Brain Tumor Amogh

    5/119

  • 8/3/2019 Brain Tumor Amogh

    6/119

    Diagnostic catheter angiography

    The use of diagnostic catheter angiography forbrain tumours has dramatically decreased withthe advances in cross-sectional imaging.

    It is occasionally performed to assess thevascular supply of meningiomas pre-operatively.

    Otherwise it is now mostly performed inconjunction with pre-operative or palliative

    tumour embolizations or intra-arterialchemotherapy for treatment of high-gradegliomas

  • 8/3/2019 Brain Tumor Amogh

    7/119

  • 8/3/2019 Brain Tumor Amogh

    8/119

    Magnetic resonance imaging

    MRI is the preferred investigation of patients with

    suspected intracranial tumours.

    It provides a better soft-tissue differentiation and

    tumour delineation than CT and advanced MRimaging techniques, such as diffusion-weighted

    (DWI) and perfusion-weighted (PWI) imaging

    and MR spectroscopy (MRS), allow the

    assessment of physiological and metabolicprocesses

  • 8/3/2019 Brain Tumor Amogh

    9/119

    SPECTROSCOPY

  • 8/3/2019 Brain Tumor Amogh

    10/119

    DWI

  • 8/3/2019 Brain Tumor Amogh

    11/119

    FMRI

  • 8/3/2019 Brain Tumor Amogh

    12/119

    COMPUTED TOMOGRAPHY

    Most clinically symptomatic brain tumours

    are detectable on CT, by virtue of mass

    effect and/or altered attenuation.

    Intra-axial tumours are usually of low

    attenuation on non-enhanced CT images.

    High attenuation areas within a tumour

    indicate tumour calcification or recent

    intratumoural haemorrhage.

    ABBREVIATED WHO

  • 8/3/2019 Brain Tumor Amogh

    13/119

    ABBREVIATED WHO

    CLASSIFICATION OF BRAIN

    TUMOURS

  • 8/3/2019 Brain Tumor Amogh

    14/119

  • 8/3/2019 Brain Tumor Amogh

    15/119

  • 8/3/2019 Brain Tumor Amogh

    16/119

  • 8/3/2019 Brain Tumor Amogh

    17/119

    Approach

    Age of the patient. Intra- or extra-axial and in what anatomical compartment does it lie? Is it a solitary mass or is there multi-focal disease? On CT and MR we look for tissue characteristics like calcifications,

    fat, cystic components, contrast enhancement and signal intensity

    on T1WI, T2WI and DWI. Most brain tumors are of low signal intensity on T1WI and high onT2WI.

    Therefore high signal intensity on T1WI or low signal on T2WI canbe an important clue to the diagnosis.

    Lesion that simulates a tumor - like an abscess, MS-plaque,

    vascular malformation, aneurysm or an infarct with luxury perfusion.

  • 8/3/2019 Brain Tumor Amogh

    18/119

  • 8/3/2019 Brain Tumor Amogh

    19/119

    Incidence of CNS tumors

  • 8/3/2019 Brain Tumor Amogh

    20/119

    Age distribution

    Specific tumors occur under the ageof 2, like choroid plexus papillomas,anaplastic astrocytomas andteratomas.

    In the first decademedulloblastomas, astrocytomas,ependymomas,

    craniopharyngeomas and gliomasare most common, whilemetastases are very rare.When they do occur at this age,metastases of a neuroblastoma arethe most frequent.

    In adults about 50% of all CNSlesions are metastases. Other

    common tumors in adults areastrocytomas, glioblastomamultiforme, meningiomas,oligodendrogliomas, pituitaryadenomas and schwannomas.

    Astrocytomas occur at any age, butglioblastoma multiforme is mostlyseen in older people.

  • 8/3/2019 Brain Tumor Amogh

    21/119

    Although cancer is rare in

    children, brain tumors are

    the most common type of

    childhood cancer after

    leukemia and lymphoma.Most of the tumors in

    children are located

    infratentorially.

    The most common supra-and infratentorial tumors

    are listed in the table on

    the left.

  • 8/3/2019 Brain Tumor Amogh

    22/119

    The most common tumors in adults

    Note that metastases are byfar the most common.It is important to realise that50% of metastases aresolitary.

    Particularly in the posteriorfossa, metastases should be inthe top 3 of the differentialdiagnostic list.Hemangioblastoma is anuncommon tumor, but it is the

    most common primary intra-axial tumor in the adult.Supratentorially, metastasesare also the most commontumors, followed by gliomas.

  • 8/3/2019 Brain Tumor Amogh

    23/119

    TUMOR SPREAD

  • 8/3/2019 Brain Tumor Amogh

    24/119

    Intra- versus Extraaxial

    When we study an intracranialmass, the first thing we want toknow is whether the mass liesin- or outside of the brain.If it is outside the brain orextra-axial, then the lesion is

    not actually a brain tumor, butderived from the lining of thebrain or surroundingstructures.Eighty percent of these extra-axial lesions will be either ameningioma or aschwannoma.On the other hand, in an adultan intra-axial tumor will be ametastasis or astrocytoma in75% of cases.

  • 8/3/2019 Brain Tumor Amogh

    25/119

    Schwannoma in CPA-region with

    typical features of an extraaxial

    tumor (T2WI)

  • 8/3/2019 Brain Tumor Amogh

    26/119

    There is a CSF cleft (yellow arrow). The subarachnoid vessels that run on the surface of the brain are displaced by the

    lesion (blue arrow).

    There is gray matter between the lesion and the white matter (curved red arrow). The subarachnoid space is widened because growth of an extra-axial lesion tends topush away the brain.

    All these signs indicate that this is a typical extra-axial tumor.In the region of the CPA 90% of the extra-axial tumors are schwannomas.

  • 8/3/2019 Brain Tumor Amogh

    27/119

    Coronal enhanced T1WI. Meningioma with dural tail, hyperostosis of

    adjacent bone and homogeneous enhancement

    Another sign of an extra-axialorigin is a broad dural base ora dural tail of enhancement asis typically seen inmeningiomas.

    This may also occur in other

    extra-axial tumors, but it is lesscommon.

    Another sign of an extra-axialorigin are bony changes. Bonychanges are seen in bonetumors like chordomas,

    chondrosarcomas andmetastases.They can also be secondary,as is seen in meningiomas andother tumors

  • 8/3/2019 Brain Tumor Amogh

    28/119

    Melanoma metastasis

    This lesion surely has the appearance of a meningioma: these tumors canbe hypointense on T2 due to a fibrocollageneous matrix or calcificationsand frequently produce reactive edema in the adjacent white matter of thebrain.

    However, there is gray matter on the anteromedial and posteromedial sideof the lesion (red arrow).

    This indicates that the lesion is intra-axial.

  • 8/3/2019 Brain Tumor Amogh

    29/119

    Local tumor spread

    Astrocytomas spread along the white matter tracts and do not respect the bounderiesof the lobes.

    Because of this infiltrative growth, in many cases the tumor is actually larger than canbe depicted with MR.

    Ependymomas of the fourth ventricle in children tend to extend through the foramenof Magendie to the cisterna magna and through the lateral foramina of Luschka to thecerebellopontine angle

    Oligodendrogliomas typically show extension to the cortex.

  • 8/3/2019 Brain Tumor Amogh

    30/119

    Subarachnoid seeding

    Some tumors show subarachnoid seeding andform tumoral nodules along the brain and spinalcord.

    This is seen in PNET, ependymomas, GBMs,lymphomas, oligodendrogliomas and choroidplexus papillomas.

    Primitive neuroectodermal tumours (PNET) form

    a rare group of tumors, which develop fromprimitive or undifferentiated nerve cells.These include medulloblastomas andpineoblastomas

  • 8/3/2019 Brain Tumor Amogh

    31/119

    One of the most important roles of imaging is to assess the extent ofa tumor.

    This is shown in the case on the left in a patient who presented withmultiple cranial nerve abnormalities.On the images we see an extra-axial tumor in the region of the leftcavernous sinus. There is homogeneous enhancement with a broaddural tail.This is typical for a meningioma.

  • 8/3/2019 Brain Tumor Amogh

    32/119

    MASS EFFECT

    Another important consideration is the effect on

    the surrounding structures.

    Primary brain tumors are derived from brain cells

    and often have less mass effect for their sizethan you would expect, due to their infiltrative

    growth.

    This is not the case with metastases and extra-

    axial tumors like meningiomas or schwannomas,which have more mass effect due to their

    expansive growth.

  • 8/3/2019 Brain Tumor Amogh

    33/119

    Diffusely infiltrating intra-axial tumor occupying most ofthe right hemisphere with only a minimal mass effect.

    This is typical for the infiltrative growth seen in primarybrain tumors. There is no enhancement so this would probably be a

    low-grade astrocytoma.

  • 8/3/2019 Brain Tumor Amogh

    34/119

    MIDLINECROSSING

  • 8/3/2019 Brain Tumor Amogh

    35/119

    Multifocal disease

    Multiple tumors in the brain usually indicatemetastatic disease

    Primary brain tumors are typically seen in asingle region, but some brain tumors like

    lymphomas, multicentric glioblastomas andgliomatosis cerebri can be multifocal.

    Some tumors can be multifocal as a result ofseeding metastases: this can occur in

    medulloblastomas (PNET-MB), ependymomas,GBMs and oligodendrogliomas. Meningiomas and schwannomas can be

    multiple, especially in neurofibromatosis type II.

  • 8/3/2019 Brain Tumor Amogh

    36/119

    Multiple brain tumors can be seen

    in phacomatoses:

    1. Neurofibromatosis II: meningiomas,

    ependymomas, optic nerve gliomas,

    choroid plexus papillomas

    2. Tuberous Sclerosis: subependymal

    tubers, intraventricular giant cell

    astrocytomas, ependymomas

    3. von Hippel Lindau: hemangioblastomas

  • 8/3/2019 Brain Tumor Amogh

    37/119

    Many non-tumorous diseases like small

    vessel disease, infections (septic emboli,

    abscesses) or demyelinating diseases like

    MS can also present as multifocal disease.

  • 8/3/2019 Brain Tumor Amogh

    38/119

    LEFT: Metastases.

    RIGHT: Multiple meningiomas and a schwannoma

    in a patient with Neurofibromatosis II

  • 8/3/2019 Brain Tumor Amogh

    39/119

    Cortical based tumors

    Most intra-axial tumors are located in thewhite matter.Some tumors, however,spread to or are located in the gray matter.

    The differential diagnosis for these corticalbased tumors includes oligodendroglioma,ganglioglioma and DysembryoplasticNeuroepithial Tumor (DNET).

    Patients with a cortically based tumorusually present with complex seizures.

    A DNET is a rare benign neoplasm, usually in a cortical and temporal location.

  • 8/3/2019 Brain Tumor Amogh

    40/119

    45-year-old female with a stable seizure disorder(complex-partial) for 15 years.

    There is a non-enhancing, cortically based tumor. This is a ganglioglioma. The differential diagnosis includes DNET and pilocytic

    astrocytoma.

  • 8/3/2019 Brain Tumor Amogh

    41/119

    These cortically based tumors have to be

    differentiated from non-tumorous lesions

    like cerebritis, herpes simplex

    encephalitis, infarction and post-ictalchanges.

  • 8/3/2019 Brain Tumor Amogh

    42/119

    Oligodendroglioma

    52-year-old female who, overthe period of one year,complained of headache andneck pain. There is a recentonset of tonic-clonic seizures.The CT shows a mass with

    calcifications, which extendsall the way to the cortex.Although this is a large tumorthere is only limited masseffect on surroundingstructures, which indicates thatthis is an infiltrating tumor.

    The most likely diagnosis is.The differential diagnosisincludes a malignantastrocytoma or a glioblastoma.

  • 8/3/2019 Brain Tumor Amogh

    43/119

    CT and MR Characteristics

  • 8/3/2019 Brain Tumor Amogh

    44/119

    Fat - Calcification - Cyst

    Fat has a low density on CT (- 100HU).On MR, fat has a high signal intensity on both T1- andT2WI.

    On sequences with fat suppression fat can be

    differentiated from high signal caused by subacutehematoma, melanin, slow flow etc.

    When you see high signal on T1WI always look forchemical shift artefact, as this indicates the presence offat.The chemical shift artefact occurs as alternating bands

    of high and low signal on the boundaries of a lesion and isseen only in the frequency encoding direction.

  • 8/3/2019 Brain Tumor Amogh

    45/119

    Ruptured dermoid cyst.

    Fat within a tumor is seen in lipomas, dermoidcysts and teratomas.

    Some tumors can have a high density on CT.This is typically seen in lymphoma, colloid cyst

    and PNET-MB (medulloblastoma

  • 8/3/2019 Brain Tumor Amogh

    46/119

    Calcification

  • 8/3/2019 Brain Tumor Amogh

    47/119

    Calcified mass in the

    suprasellar region,

    causing obstructive

    hydrocephalus. This location in the

    suprasellar region and

    the calcification are

    typical for acraniopharyngioma.

  • 8/3/2019 Brain Tumor Amogh

    48/119

    Craniopharyngiomas are slow growing,

    extra-axial, squamous epithelial, calcified,

    cystic tumors arising from remnants of

    Rathke's cleft.

    They are located the (supra)sellar region

    and primarily seen in children with a small

    second peak incidence in older adults.

  • 8/3/2019 Brain Tumor Amogh

    49/119

    The calcification is not appreciated on the MR images, but

    is easily seen on CT.

    The calcification and the extension of the tumor to the

    cortex are very typical for an oligodendroglioma.

    An astrocytoma should be in the differential.

  • 8/3/2019 Brain Tumor Amogh

    50/119

    Calcified meningioma

    A patient with progressive visual loss.On the coronal and sagittal TW1I there is a large mass centeredaround the sella with a broad dural base.

    There is extension into the sella.This patient was booked for decompression.

    Only after the CT was performed, was it appreciated how denselycalcified this tumor is.

  • 8/3/2019 Brain Tumor Amogh

    51/119

    Cystic versus Solid

    There are many cystic lesions that can

    simulate a CNS tumor.

    These include epidermoid, dermoid,

    arachnoid, neuroenteric and neuroglial

    cysts.

    Even enlarged perivascular spaces of

    Virchow Robin can simulate a tumor.

  • 8/3/2019 Brain Tumor Amogh

    52/119

    In order to determine whether a lesion

    is a cyst or cystic mass look for the

    following characteristics:

    Morphology

    Fluid/fluid level

    Content usually isointense to CSF on T1,

    T2 and FLAIR

    DWI: restricted diffusion

  • 8/3/2019 Brain Tumor Amogh

    53/119

    An arachnoid cyst is isointense to CSF on

    all sequences.

    Tumor necrosis may sometimes look like a

    cyst, but it is never completely isointense

    to CSF.

  • 8/3/2019 Brain Tumor Amogh

    54/119

    Craniopharyngioma with an enhancing rim surrounding the cysticcomponent.

    Neuroenteric cyst with the contents of which have the same signalintensity as CSF.

    Glioblastoma multiforme (GBM) with a central cystic component.The enhancement in GBM is usually more irregular.

  • 8/3/2019 Brain Tumor Amogh

    55/119

    MOST LESIONS ARE LOW ON

    T1 AND HIGH ON T2

    BUT.......

  • 8/3/2019 Brain Tumor Amogh

    56/119

  • 8/3/2019 Brain Tumor Amogh

    57/119

    A patient who presented with apoplexy. The high signal is due tohemorrhage in a pituitary macroadenoma.

    The patient in the middle has a glioblastoma multiforme, whichcaused a hemorrhage in the splenium of the corpus callosum.

    On the right is a patient with a metastasis of a melanoma.The high signal intensity is due to the melanin content.

  • 8/3/2019 Brain Tumor Amogh

    58/119

  • 8/3/2019 Brain Tumor Amogh

    59/119

    Low on T2

    Most tumors will be bright on T2WI due toa high water content.

    When tumors have a low water content

    they are very dense and hypercellular andthe cells have a high nuclear-cytoplasmasmic ratio.

    These tumors will be dark on T2WI.The classic examples are CNS lymphomaand PNET (also hyperdense on CT).

  • 8/3/2019 Brain Tumor Amogh

    60/119

    Calcifications are mostly dark on T2WI. Paramagnetic effects cause a signal drop and

    are seen in tumors that contain hemosiderin. Proteinaceous material can be dark on T2

    depending on the content of the protein itself.A classic example of this is the colloid cyst.

    Flow voids are also dark on T2 and indicate thepresence of vessels or flow within a lesion.

    This is seen in tumors that contain a lot ofvessels like hemangioblastomas, but also innon-tumorous lesions like vascularmalformations

  • 8/3/2019 Brain Tumor Amogh

    61/119

    Melanoma metastases have a low SI on T2WI as a result of themelanin.

    GBM can have a low SI on T2WI because sometimes they have a

    high nuclear-cytoplasmic ratio. Most GBM's, however, arehyperintense on T2WI. PNET typically has a high nuclear-cytoplasmic ratio. PNET is

    mostly located in the region of the 4th ventricle, but another, lesscommon, location is in the region of the pineal gland.

  • 8/3/2019 Brain Tumor Amogh

    62/119

    Mucinous metastases can have a low SI on T2WI because theyoften contain calcifications..

    Meningiomas are mostly of intermediate signal.

    They can have a high SI on T2WI if they contain a lot of water.They can have a low SI on T2WI if they are very dense andhypercellular or when they contain calcifications.

  • 8/3/2019 Brain Tumor Amogh

    63/119

  • 8/3/2019 Brain Tumor Amogh

    64/119

    Diffusion weighted imaging

    Normally water protons have the ability to diffuseextracellularly and loose signal.High intensity on DWI indicates restriction of the ability ofwater protons to diffuse extracellularly.Restricted diffusion is seen in abscesses, epidermoidcysts and acute infarction (due to cytotoxic edema).

    In cerebral abscesses the diffusion is probably restricteddue to the viscosity of pus, resulting in a high signal onDWI.

    In most tumors there is no restricted diffusion - even innecrotic or cystic components.This results in a normal, low signal on DWI.

  • 8/3/2019 Brain Tumor Amogh

    65/119

  • 8/3/2019 Brain Tumor Amogh

    66/119

    Perfusion Imaging

    Perfusion imaging can play an important role in

    determining the malignancy grade of a CNS

    tumor.

    Perfusion depends on the vascularity of a tumorand is not dependent on the breakdown of the

    blood-brain barrier.

    The amount of perfusion shows a better

    correlation with the grade of malignancy of atumor than the amount of contrast enhancement.

  • 8/3/2019 Brain Tumor Amogh

    67/119

  • 8/3/2019 Brain Tumor Amogh

    68/119

  • 8/3/2019 Brain Tumor Amogh

    69/119

    Blood brain barrier

    The brain has a unique triple layered

    blood-brain barrier (BBB) with tight

    endothelial junctions in order to maintain a

    consistent internal milieu. Contrast will not leak into the brain unless

    this barrier is damaged.

    Enhancement is seen when a CNS tumordestroys the BBB.

  • 8/3/2019 Brain Tumor Amogh

    70/119

    Extra-axial tumors such as meningiomas

    and schwannomas are not derived from

    brain cells and do not have a blood-brain

    barrier. Therefore they will enhance. There is also no blood-brain barrier in the

    pituitary, pineal and choroid plexus

    regions.

  • 8/3/2019 Brain Tumor Amogh

    71/119

    Some non-tumoral lesions enhance

    because they can also break down the

    BBB and may simulate a brain tumor.

    These lesions include like infections,demyelinating diseases (MS) and

    infarctions.

  • 8/3/2019 Brain Tumor Amogh

    72/119

    Contrast enhancement cannot visualize the full

    extent of a tumor in cases of infiltrating tumors,

    like gliomas.

    The reason for this is that tumor cells blend withthe normal brain parenchyma where the blood

    brain barrier is still intact.

    Tumor cells can be found beyond the enhancing

    margins of the tumor and beyond any MR signalalteration - even beyond the area of edema.

  • 8/3/2019 Brain Tumor Amogh

    73/119

    42 y/o male with mild head trauma. On the T2WI there is a lesion in the left temporal lobe, found

    incidentally.

    There was no enhancement and the DWI was normal. During follow-up there was a slight increase in size.

    This was diagnosed as a low-grade astrocytoma.

  • 8/3/2019 Brain Tumor Amogh

    74/119

    In gliomas - like astrocytomas,

    oligodendrogliomas and glioblastoma

    multiforme - enhancement usually

    indicates a higher degree of malignancy. Therefore when during the follow up of a

    low-grade glioma the tumor starts to

    enhance, it is a sign of malignanttransformation..

  • 8/3/2019 Brain Tumor Amogh

    75/119

    Gangliogliomas and pilocytic astrocytomas are

    the exceptions to this rule: they are low-grade

    tumors, but they enhance vividly.

  • 8/3/2019 Brain Tumor Amogh

    76/119

    The amount of enhancement depends onthe amount of contrast that is delivered tothe interstitium.

    In general, the longer we wait, the betterthe interstitial enhancement will be.The optimal timing is about 30 minutesand it is better to give contrast at the start

    of the examination and to do theenhanced T1WI at the end.

  • 8/3/2019 Brain Tumor Amogh

    77/119

    LEFT: Schwannoma extending into the middle

    cranial fossa with homogeneous enhancement

    RIGHT: Primary Lymphoma known for its vividenhancement

  • 8/3/2019 Brain Tumor Amogh

    78/119

    No enhancement is seen in

    Low grade astrocytomas

    Cystic non-tumoral lesions:

    Dermoid cyst

    Epidermoid cyst

    Arachnoid cyst

  • 8/3/2019 Brain Tumor Amogh

    79/119

    An intra-axial tumor in an adult. It is centered in the temporal lobe and involves the cortex.Although there is massive infiltrative growth involving a large part ofthe right cerebral hemisphere, there is only minimal mass effect.

    There is no enhancement.

    These features are typical for a low-grade astrocytoma.

    H h

  • 8/3/2019 Brain Tumor Amogh

    80/119

    Homogeneous enhancement

    Metastases

    Lymphoma

    Germinoma and other pineal gland tumors Pituitary macroadenoma

    Pilocytic astrocytoma and hemangioblastoma(only the solid component)

    Ganglioglioma Meningioma and Schwannoma

  • 8/3/2019 Brain Tumor Amogh

    81/119

    P t h h t

  • 8/3/2019 Brain Tumor Amogh

    82/119

    Patchy enhancement

    Metastases

    Oligodendroglioma

    Glioblastoma multiforme

    Radiation necrosis

  • 8/3/2019 Brain Tumor Amogh

    83/119

    Gioblastoma multiforme (GBM). The enhancement indicates that this is a high-grade tumor, but only

    parts of it enhance. There is also a cystic component with ringenhancement.

    The tumor cells probably extend beyond the area of edema as seenon the FLAIR image.This is because gliomas grow infiltratively into normal brain - initiallywithout any MR changes.

  • 8/3/2019 Brain Tumor Amogh

    84/119

    Although is a large tumor, the mass-effect is limited.This indicates that there is marked infiltrative growth, acharacteristic typical for gliomas.

    Notice the heterogeneity on both T2WI and FLAIR.

    There is patchy enhancement.All these findings are typical for a GBM.Virtually no other tumor behaves in this way.

  • 8/3/2019 Brain Tumor Amogh

    85/119

    Ri h t

  • 8/3/2019 Brain Tumor Amogh

    86/119

    Ring enhancement

    Ring enhancement is seen in metastasesand high-grade gliomas.

    It is also seen in non-tumorous lesions like

    abscesses, some MS-plaques andsometimes in an old hematomas.

  • 8/3/2019 Brain Tumor Amogh

    87/119

  • 8/3/2019 Brain Tumor Amogh

    88/119

    Conspicuity of tumors with contrast

    This is a patient with Neurofibromatosis II.

    After the administration of contrast the twomeningiomas and the schwannoma are easilyseen.

  • 8/3/2019 Brain Tumor Amogh

    89/119

    Leptomeningeal metastases are usually not seen without theadministration of intravenous contrast.

    The case on the left demonstrates the abnormal enhancement

    along the brainstem, along the folia of the cerebellum (yellow arrow)and along the fifth intracranial nerve (blue arrow) in a patient withleptomeningeal metastases.

  • 8/3/2019 Brain Tumor Amogh

    90/119

    Differential diagnosis

    for specific anatomic area

  • 8/3/2019 Brain Tumor Amogh

    91/119

    Sk ll base

  • 8/3/2019 Brain Tumor Amogh

    92/119

    Skull base

    These tumors either arise fromextracranial structures like the sinuses

    (sinonasal carcinoma), or from the skull

    base itself (chordoma, chondrosarcoma,fibrous dysplasia).

    Chordoma is usually located in the

    midline, while chondrasarcoma usuallyarises off the midline.

  • 8/3/2019 Brain Tumor Amogh

    93/119

    Midline tumorarising from theclivus.

    This is the typical

    presentation of achordoma.The differentialdiagnosis would

    include ametastasis and achondrosarcoma.

  • 8/3/2019 Brain Tumor Amogh

    94/119

    Skull base tumor locatedoff midline.

    This is a typicalpresentation for achondrosarcoma.

    The differential diagnosiswould include ametastasis and aparaganglioma.Chondrosarcomas canbe located in the midline

    and chordomas aresometimes located offmidline but those casesare exceptional.

    Skull Base Paraganglioma

  • 8/3/2019 Brain Tumor Amogh

    95/119

    Skull Base Paraganglioma.

  • 8/3/2019 Brain Tumor Amogh

    96/119

    58-year-old male with a gradual onset of right facial pain andnumbness and a recent onset of double vision.

    There is an enhancing mass anterior to the skull base and also inthe region of the right cavernous sinus.In the bone window setting there is sclerosis of the skull base,particularly in the region of the clivus.

    PTO

    CONTD

  • 8/3/2019 Brain Tumor Amogh

    97/119

    A normal clivus is bright on T1WI as a result of the fatty bonemarrow.

    There is an enhancing mass anterior to the clivus.

    On the coronal images we see the enhancement extending throughthe foramen ovale to the right of the cavernous sinus.

  • 8/3/2019 Brain Tumor Amogh

    98/119

    The diagnosis is a nasopharyngealsquamous cell carcinoma with intracranial

    extension.

    The differential diagnosis would include:skull base metastasis, lymphoma, chronic

    infection and even a meningioma -

    although this would be an unusual way fora meningioma to spread.

  • 8/3/2019 Brain Tumor Amogh

    99/119

  • 8/3/2019 Brain Tumor Amogh

    100/119

    Mass in the suprasellar cistern. On the NECT we can see that it contains calcium. On the T1WI there is a hyperintense area that shows no

    enhancement (i.e. cystic). There are other components that show enhancement. The tumor is complicated by a hydrocephalus.

    These findings are very specific for a craniopharyngeoma.

  • 8/3/2019 Brain Tumor Amogh

    101/119

    PTO

  • 8/3/2019 Brain Tumor Amogh

    102/119

  • 8/3/2019 Brain Tumor Amogh

    103/119

    Notice the normal inferiorly displacedpituitary gland.

    This means it is not a macroadenoma.

    The diagnosis is a craniopharyngioma. The differential diagnosis would include an

    astrocytoma and a meningioma.

  • 8/3/2019 Brain Tumor Amogh

    104/119

  • 8/3/2019 Brain Tumor Amogh

    105/119

    52-year-old male with hearing loss on the right.The images show an unusual cystic mass with enhancingseptations.

    There is also some enhancement within the internal acoustic canal.Based on the images the most likely diagnosis would be a cysticschwannoma, but this happened to be an uncommon, cysticpresentation of a meningioma.

  • 8/3/2019 Brain Tumor Amogh

    106/119

  • 8/3/2019 Brain Tumor Amogh

    107/119

  • 8/3/2019 Brain Tumor Amogh

    108/119

    Based on these images the differentialdiagnosis would include:

    Meningioma

    Pineocytoma

    Germ Cell Tumor

    This happened to be a meningioma.

    Ruptured pineal region dermoid

  • 8/3/2019 Brain Tumor Amogh

    109/119

    Ruptured pineal region dermoid.

  • 8/3/2019 Brain Tumor Amogh

    110/119

    12 y/o male with upward gaze paralysis.

    There is a tumor located in the pineal region. The tumor contains calcifications. There is homogeneous enhancement, which is common for a tumor

    in the pineal regionBased on the age of the patient, the location and the tumorcharacteristics, this is most likely a germinoma.

  • 8/3/2019 Brain Tumor Amogh

    111/119

    Giant cell astrocytoma

  • 8/3/2019 Brain Tumor Amogh

    112/119

    Giant cell astrocytoma.

    4th ventricle

  • 8/3/2019 Brain Tumor Amogh

    113/119

    4th ventricle

  • 8/3/2019 Brain Tumor Amogh

    114/119

    In children tumors in the 4th ventricle are verycommon.

    Astrocytomas are the most common followed bymedulloblastomas (or PNET-MB),

    ependymomas and brainstem gliomas with adorsal exophytic component.

    In adults tumors in the 4th ventricle areuncommon.

    Metastases are most frequently seen, followedby hemangioblastomas, choroid plexuspapillomas and dermoid and epidermoid cysts.

    Tumor Mimics

  • 8/3/2019 Brain Tumor Amogh

    115/119

    Many non-tumorous lesions can mimic abrain tumor.

    Abscesses can mimic metastases.

    Multiple sclerosis can present with amass-like lesion with enhancement, also

    known as tumefactive multiple sclerosis..

    In the parasellar region one should alwaysconsider the possibility of a aneurysm

  • 8/3/2019 Brain Tumor Amogh

    116/119

  • 8/3/2019 Brain Tumor Amogh

    117/119

    References

    http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552
  • 8/3/2019 Brain Tumor Amogh

    118/119

    References

    Brain Lesion Locator: Differential Diagnosis by Locat

    by James Smirniotopoulos

    Diagnostic Neuroradiology by Anne G. Osborn

    Textbook ofRadiology and Imaging David

    Sutton 7ed

    Grainger & Allison's Diagnostic Radiology

    www.radiologyassistant.nl

    http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://rad.usuhs.mil/rad/location/location_frame.htmlhttp://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://www.elsevier.com/wps/product/authors/712552http://thepiratebay.org/torrent/4265111/Textbook_of_Radiology_and_Imaging_David_Sutton_7edhttp://thepiratebay.org/torrent/4265111/Textbook_of_Radiology_and_Imaging_David_Sutton_7edhttp://thepiratebay.org/torrent/4265111/Textbook_of_Radiology_and_Imaging_David_Sutton_7edhttp://thepiratebay.org/torrent/4265111/Textbook_of_Radiology_and_Imaging_David_Sutton_7edhttp://thepiratebay.org/torrent/4265111/Textbook_of_Radiology_and_Imaging_David_Sutton_7edhttp://rad.usuhs.mil/rad/location/location_frame.html
  • 8/3/2019 Brain Tumor Amogh

    119/119